IBM Join Hands With Boehringer Ingelheim To Trial Blockchain in Clinical Recordkeeping February 13, 2019 February 13, 2019 Kelly Cromley http://1AZFjzw2#Nwf63pYaMWq#xIY
Market NewsFebruary 13, 2019 by Kelly Cromley

IBM Join Hands With Boehringer Ingelheim To Trial Blockchain in Clinical Recordkeeping

IBM’s Canadian division has collaborated with Boehringer Ingelheim, a pharmaceutical company to install a blockchain powered platform for clinical recordkeeping. Specifically, both parties intend to assess whether blockchain technology has the ability to provide necessary level of data integrity, patient safety and transparency in addition to cutting costs and mechanize processes related to clinical recordkeeping.

Dr. Uli Broedl, Vice President, Medical and Regulatory Affairs, Boehringer Ingelheim (Canada) said, “The clinical trial ecosystem is highly complex as it involves different stakeholders, resulting in limited trust, transparency and process inefficiencies without true patient empowerment.”

According to the agreement, IBM will provide the project with blockchain technology to assure transparency and trust during the trial. This is not the first project for IBM. It is involved in over 400 blockchain related projects. Back in January, the tech company joined hands with the US insurance giant Aetna to develop a blockchain network customized for the healthcare industry.

The blockchain based platform is forecast to serve more than 39 million clients worldwide by simplifying insurance claims processing and payment remittance, in addition to directory management.

Boehringer Ingelheim, a pharmaceutical company focused on research and development of therapies, was founded in 1885. In 2017, the company generated revenue of around €18 billion ($20.4 billion). In 1972, Boehringer Ingelheim established its headquarters in Montreal, Quebec.

Notably, blockchain company Bitfury striked a partnership deal with Medical Diagnostic Web (MDW), which offers blockchain platform for radiology. Under the agreement, both parties will develop a blockchain platform for sharing, maintaining and securing data pertaining to medical imaging and diagnostics, for example CT scans and X-rays.

Back in February, a medical R&D consortium, referred to as the Pistoia Alliance, broadened its blockchain venture to include data identity, data sharing and data integrity. The project will concentrate on the use of blockchain to assess sources in identifying data and enhance sharing between organizations.

AuthorKelly Cromley

Kelly is our in house crytpto researcher, delving into the stories which matter from blockchains being used in the real world to new ico coming out.